Literature DB >> 23006848

Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.

Marie-Alice Vitry1, Carl De Trez, Stanislas Goriely, Laure Dumoutier, Shizuo Akira, Bernhard Ryffel, Yves Carlier, Jean-Jacques Letesson, Eric Muraille.   

Abstract

Brucella spp. are facultative intracellular bacterial pathogens responsible for brucellosis, a worldwide zoonosis that causes abortion in domestic animals and chronic febrile disease associated with serious complications in humans. There is currently no approved vaccine against human brucellosis, and antibiotic therapy is long and costly. Development of a safe protective vaccine requires a better understanding of the roles played by components of adaptive immunity in the control of Brucella infection. The importance of lymphocyte subsets in the control of Brucella growth has been investigated separately by various research groups and remains unclear or controversial. Here, we used a large panel of genetically deficient mice to compare the importance of B cells, transporter associated with antigen processing (TAP-1), and major histocompatibility complex class II-dependent pathways of antigen presentation as well as T helper 1 (Th1), Th2, and Th17-mediated responses on the immune control of Brucella melitensis 16 M infection. We clearly confirmed the key function played by gamma interferon (IFN-γ)-producing Th1 CD4(+) T cells in the control of B. melitensis infection, whereas IFN-γ-producing CD8(+) T cells or B cell-mediated humoral immunity plays only a modest role in the clearance of bacteria during primary infection. In the presence of a Th1 response, Th2 or Th17 responses do not really develop or play a positive or negative role during the course of B. melitensis infection. On the whole, these results could improve our ability to develop protective vaccines or therapeutic treatments against brucellosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23006848      PMCID: PMC3497404          DOI: 10.1128/IAI.00761-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  74 in total

Review 1.  Th17: the third member of the effector T cell trilogy.

Authors:  Estelle Bettelli; Thomas Korn; Vijay K Kuchroo
Journal:  Curr Opin Immunol       Date:  2007-09-04       Impact factor: 7.486

2.  T(H)2 bias: Mina tips the balance.

Authors:  Saskia Hemmers; Kerri A Mowen
Journal:  Nat Immunol       Date:  2009-08       Impact factor: 25.606

3.  Evidence that CD8+ dendritic cells enable the development of gammadelta T cells that modulate airway hyperresponsiveness.

Authors:  Laura Cook; Nobuaki Miyahara; Niyun Jin; J M Wands; Christian Taube; Christina L Roark; Terry A Potter; Erwin W Gelfand; Rebecca L O'Brien; Willi K Born
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 4.  Brucellosis: the case for live, attenuated vaccines.

Authors:  Thomas A Ficht; Melissa M Kahl-McDonagh; Angela M Arenas-Gamboa; Allison C Rice-Ficht
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

Review 5.  Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system.

Authors:  Russell E Vance; Ralph R Isberg; Daniel A Portnoy
Journal:  Cell Host Microbe       Date:  2009-07-23       Impact factor: 21.023

Review 6.  Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens.

Authors:  Meredith M Curtis; Sing Sing Way
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

7.  Beta 2-microglobulin deficient mice catabolize IgG more rapidly than FcRn- alpha-chain deficient mice.

Authors:  Jonghan Kim; C L Bronson; Manzoor A Wani; Tatiana M Oberyszyn; Sudhasri Mohanty; Chaity Chaudhury; William L Hayton; John M Robinson; Clark L Anderson
Journal:  Exp Biol Med (Maywood)       Date:  2008-03-28

8.  Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17.

Authors:  Silke M Schulz; Gabriele Köhler; Nicole Schütze; Jens Knauer; Reinhard K Straubinger; Alissa A Chackerian; Ellen Witte; Kerstin Wolk; Robert Sabat; Yoichiro Iwakura; Christoph Holscher; Uwe Müller; Robert A Kastelein; Gottfried Alber
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

9.  Natural antibody contributes to host defense against an attenuated Brucella abortus virB mutant.

Authors:  Hortensia G Rolán; Mariana N Xavier; Renato L Santos; Renée M Tsolis
Journal:  Infect Immun       Date:  2009-04-13       Impact factor: 3.441

10.  An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.

Authors:  Karina A Pasquevich; Andrés E Ibañez; Lorena M Coria; Clara García Samartino; Silvia M Estein; Astrid Zwerdling; Paula Barrionuevo; Fernanda S Oliveira; Christine Seither; Heribert Warzecha; Sergio C Oliveira; Guillermo H Giambartolomei; Juliana Cassataro
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

View more
  44 in total

1.  Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.

Authors:  Xinghong Yang; Beata Clapp; Theresa Thornburg; Carol Hoffman; David W Pascual
Journal:  Vaccine       Date:  2016-09-14       Impact factor: 3.641

2.  B Cells Inhibit CD4+ T Cell-Mediated Immunity to Brucella Infection in a Major Histocompatibility Complex Class II-Dependent Manner.

Authors:  Alexis S Dadelahi; Carolyn A Lacey; Catherine A Chambers; Bárbara Ponzilacqua-Silva; Jerod A Skyberg
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

3.  Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.

Authors:  Arnaud Machelart; Abir Khadrawi; Aurore Demars; Kevin Willemart; Carl De Trez; Jean-Jacques Letesson; Eric Muraille
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

4.  Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.

Authors:  Morteza Abkar; Abbas Sahebghadam Lotfi; Jafar Amani; Khadijeh Eskandari; Mehdi Fasihi Ramandi; Jafar Salimian; Gholamreza Nikbakht Brujeni; Saeed Alamian; Mehdi Kamali; Hamid Koushki
Journal:  Vet Res Commun       Date:  2015-09-22       Impact factor: 2.459

Review 5.  Alternative strategies for vaccination to brucellosis.

Authors:  David W Pascual; Xinghong Yang; Hongbin Wang; Zakia Goodwin; Carol Hoffman; Beata Clapp
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

6.  Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.

Authors:  Jonathan W Willett; Julien Herrou; Daniel M Czyz; Jason X Cheng; Sean Crosson
Journal:  Vaccine       Date:  2016-08-31       Impact factor: 3.641

7.  Attenuated Mutants of Ehrlichia chaffeensis Induce Protection against Wild-Type Infection Challenge in the Reservoir Host and in an Incidental Host.

Authors:  Arathy D S Nair; Chuanmin Cheng; Deborah C Jaworski; Suhasini Ganta; Michael W Sanderson; Roman R Ganta
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

8.  Innate immune recognition of flagellin limits systemic persistence of Brucella.

Authors:  Jean-Jacques Letesson; Renée M Tsolis; Matthieu Terwagne; Jonathan Ferooz; Hortensia G Rolán; Yao-Hui Sun; Vidya Atluri; Mariana N Xavier; Luigi Franchi; Gabriel Núñez; Thomas Legrand; Richard A Flavell; Xavier De Bolle
Journal:  Cell Microbiol       Date:  2013-01-07       Impact factor: 3.715

9.  CXCR2 Mediates Brucella-Induced Arthritis in Interferon γ-Deficient Mice.

Authors:  Carolyn A Lacey; Lauren L Keleher; William J Mitchell; Charles R Brown; Jerod A Skyberg
Journal:  J Infect Dis       Date:  2016-03-06       Impact factor: 5.226

10.  CD8+ T cell exhaustion, suppressed gamma interferon production, and delayed memory response induced by chronic Brucella melitensis infection.

Authors:  Marina Durward-Diioia; Jerome Harms; Mike Khan; Cherisse Hall; Judith A Smith; Gary A Splitter
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.